SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020630
Filing Date
2020-11-06
Accepted
2020-11-06 06:30:46
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1357083
2 form10q_001.jpg GRAPHIC 6593
3 ex31-1.htm EX-31.1 11201
4 ex31-2.htm EX-31.2 11238
5 ex32-1.htm EX-32.1 8348
  Complete submission text file 0001493152-20-020630.txt   5609367

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mtnb-20200930.xsd EX-101.SCH 45916
7 XBRL CALCULATION FILE mtnb-20200930_cal.xml EX-101.CAL 54646
8 XBRL DEFINITION FILE mtnb-20200930_def.xml EX-101.DEF 129764
9 XBRL LABEL FILE mtnb-20200930_lab.xml EX-101.LAB 353037
10 XBRL PRESENTATION FILE mtnb-20200930_pre.xml EX-101.PRE 249582
11 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 954884
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 201292326
SIC: 2834 Pharmaceutical Preparations